- •A shorter reproductive lifespan was associated with higher risk of type 2 diabetes and hypertension.
- •The risks of type 2 diabetes and hypertension were more pronounced in women experiencing a short reproductive lifespan and obesity at midlife.
- •Reproductive lifespan combined with obesity/weight gains could serve as a marker of cardiovascular risk factors at midlife.
Abbreviations:BMI (body mass index), CVD (cardiovascular disease), HR (hazard ratio), MHT (menopausal hormone therapy), RLS (reproductive lifespan), SD (standard deviation), T2DM (type 2 diabetes mellitus)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.Lancet N. Am. Ed. 2020; 395: 795-808
Olsen M.H., Angell S.Y., Asma S., et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. 2016; 388(10060): 2665–712.
Australian Institute of Health and Welfare. Risk factors to health. 2019. https://www.aihw.gov.au/reports/biomedical-risk-factors/risk-factors-to-health/contents/high-blood-pressure (accessed December 16 2019).
Heart Foundation. High blood pressure statistics. https://www.heartfoundation.org.au/about-us/what-we-do/heart-disease-in-australia/high-blood-pressure-statistics (accessed December 16 2019).
Mishra S.R., Waller M., Chung H.F., Mishra G.D. Epidemiological studies of the association between reproductive lifespan characteristics and risk of type 2 diabetes and hypertension: a systematic review. 2022;155:14–23.
Brand J.S., Van Der Schouw Y.T., Onland-Moret N.C., et al. Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study. 2013; 36(4): 1012–9.
- Duration of reproductive life span, age at menarche, and age at menopause are associated with risk of cardiovascular disease in women.J. Am. Heart Assoc. 2017; 6e006713.
- Duration of ovarian hormone exposure and atherosclerotic cardiovascular disease in Korean women: the Korean heart study.Menopause. 2016; 23: 60-66
- Duration of reproductive years and the risk of cardiovascular and cerebrovascular events in older women: insights from the national health and nutrition examination survey.J. Women's Health. 2017; 26: 1047-1052
- Reproductive risk factors for cardiovascular disease mortality among postmenopausal women in Korea: the Kangwha cohort study, 1985–2005.Menopause. 2011; 18: 1205-1212
- Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study.J. Epidemiol. 2006; 16: 177-184
- Lifetime estrogen exposure versus age at menopause as mortality predictor.Maturitas. 2002; 43: 105-112
- Age at menarche and natural menopause and number of reproductive years in association with mortality: results from a median follow-up of 11.2 years among 31,955 naturally menopausal Chinese women.PLoS One. 2014; 9e103673
- Lower age at menarche affects survival in older Australian women: results from the Australian longitudinal study of ageing.BMC Public Health. 2010; 10: 341
- Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's health initiative.Menopause J. N. Am. Menopause Soc. 2017; 24: 35-44
- Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women.Diabetes Care. 2014; 37: 725-733
- Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's health initiative.Menopause. 2017; 24: 64-72
- Menstrual and reproductive factors and type 2 diabetes risk: the Japan public health center-based prospective study.J. Diabetes Investig. 2019; 10: 147-153
- Reproductive factors and risk of type 2 diabetes in an occupational cohort of Chinese women.J. Diabetes Complicat. 2016; 30: 1217-1222
- Menopause characteristics, total reproductive years, and risk of cardiovascular disease among Chinese women.Circ. Cardiovasc. Qual. Outcomes. 2017; 10e004235
- Association between age at natural menopause and risk of type 2 diabetes in postmenopausal women with and without obesity.J. Clin. Endocrinol. Metab. 2019; 104: 3039-3048
- Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women.J. Clin. Endocrinol. Metabol. 2008; 93: 3847-3852
- Short-term weight change and the incidence of diabetes in midlife: results from the Australian longitudinal study on women's health.Diabetes Care. 2007; 30: 1418-1424
- Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men.Am. J. Epidemiol. 2004; 159: 1150-1159
- Quantitative relationship between body weight gain in adulthood and incident type 2 diabetes: a meta-analysis.Obes. Rev. 2014; 15: 202-214
- Cohort profile update: Australian longitudinal study on women's health.Int. J. Epidemiol. 2015; 44
- Cohort profile: the Australian longitudinal study on women's health.Int. J. Epidemiol. 2005; 34: 987-991
- The impact of attrition in an 11-year prospective longitudinal study of younger women.Ann. Epidemiol. 2010; 20: 318-321
- Using Australian pharmaceutical benefits scheme data for pharmacoepidemiological research: challenges and approaches.Public Health Res. Pract. 2015; 25e2541546
- Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort.Circulation. 2014; (CIRCULATIONAHA. 114.010070)
- Early menarche, nulliparity and the risk for premature and early natural menopause.Hum. Reprod. 2017; 32: 679-686
- Association of the length of oestrogen exposure with risk of incident stroke in postmenopausal women: insights from a 20-year prospective study.Int. J. Cardiol. 2021; 328: 206-214
- Duration of oestrogen exposure during reproductive years, age at menarche and age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: a systematic review and meta-analysis.BJOG Int. J. Obstet. Gynaecol. 2021; 128: 809-821
- Identification of diabetes, heart disease, hypertension and stroke in mid-and older-aged women: comparing self-report and administrative hospital data records.Geriatr. Gerontol. Int. 2016; 16: 95-102
- How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006–2014).Br. J. Clin. Pharmacol. 2016; 82: 1134-1145
World Health Organization. Obesity: preventing and managing the global epidemic: world Health Organization; 2000;894:1–253.
- SAS/STAT® 13.1 User's Guide.SAS Institute Inc, Cary, NC2013 (Available from: https://support.sas.com/documentation/onlinedoc/stat/131/phreg.pdf (accessed April 25 2019))
Bjelland E.K., Hofvind S., Byberg L., Eskild A.. The relation of age at menarche with age at natural menopause: a population study of 336 788 women in Norway. 2018; 33(6): 1149–57.
Goldfarb I., Accenture A., Mitchell Kotler P. Application of Criterion I2 in Clinical Trials Using SAS®.2019. Available from: https://www.pharmasug.org/proceedings/2019/ST/PharmaSUG-2019-ST-314.pdf (accessed April 28 2019).
- SAS/STAT® 13.1 User's Guide The PHREG Procedure.North Carolina SAS Institute Inc, 2013
- Age at menarche and type 2 diabetes risk.Diabetes Care. 2013; 36: 3526-3534
- Age at menarche, the leg length to sitting height ratio, and risk of diabetes in middle-aged and elderly Chinese men and women.PLoS One. 2012; 7
- Oestrogens and insulin secretion.Diabetologia. 2005; 48: 2213-2220
- Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1.Diabetes. 2019; 68: 291-304
Woodard G.A., Brooks M.M., Barinas-Mitchell E., Mackey R.H., Matthews K.A., Sutton-Tyrrell K.J.M. Lipids, menopause, and early atherosclerosis in study of women's health across the nation heart women. 2011; 18(4): 376–84.
- Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.Diabetologia. 2004; 47: 1175-1187
- Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US preventive services task force.JAMA. 2017; 318: 2234-2249
- Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.JAMA. 2013; 310: 1353-1368
- Novel mechanisms responsible for postmenopausal hypertension.Hypertension. 2004; 43: 918-923
- Women's health in menopause with a focus on hypertension.Neth. Heart J. 2009; 17: 68-72
- Genetic polymorphisms and obesity influence estradiol decline during the menopause.Clin. Endocrinol. (Oxf). 2011; 74: 618-623
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.Lancet N. Am. Ed. 2016; 387: 957-967
- Body mass index and age at natural menopause: an international pooled analysis of 11 prospective studies.Eur. J. Epidemiol. 2018; 33: 699-710
- Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: a pooled analysis of individual data from 17 observational studies.PLoS Med. 2018; 15e1002704
- Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure.J. Clin. Epidemiol. 2004; 57: 1096-1103
- A validation study on status and age of natural menopause reported in the E3N cohort.Maturitas. 1998; 29: 99-103
- Validity and reproducibility of self-reported age at menopause in women participating in the DOM-project.Maturitas. 1997; 27: 117-123
Cooper R., Blell M., Hardy R., et al. Validity of age at menarche self-reported in adulthood. 2006; 60(11): 993–7.
Terry M.B., Ferris J.S., Tehranifar P., Wei Y., Flom J.D. Birth weight, postnatal growth, and age at menarche. 2009; 170(1): 72–9.
- Commentary: Mendelian randomization and women's health.Int. J. Epidemiol. 2019; 48: 830